Expert Review of Vaccines, Volume 14, Issue 9 (2015)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Vaccines, Volume 14, Issue 9 (2015)

See all volumes and issues
Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Volume 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs Download issue

Editorial

Editorial
The case for vaccine development in the strategy to eradicate river blindness (onchocerciasis) from Africa
Benjamin L Makepeace, Simon A Babayan, Sara Lustigman & David W Taylor
Pages: 1163-1165
Published online: 19 Jun 2015
AbstractforThe case for vaccine development in the strategy to eradicate river blindness (onchocerciasis) from Africa | Full Text | References | PDF (486.8 KB)
  • 1734 Views
  • 18 CrossRef citations
  • 0Altmetric
Free Access

Vaccine Profile

The Vero cell-derived, inactivated, SA14-14-2 strain-based vaccine (Ixiaro) for prevention of Japanese encephalitis
Elina O Erra & Anu Kantele
Pages: 1167-1179
Published online: 10 Jul 2015
AbstractforThe Vero cell-derived, inactivated, SA14-14-2 strain-based vaccine (Ixiaro) for prevention of Japanese encephalitis | Full Text | References | PDF (325.9 KB)
  • 498 Views
  • 23 CrossRef citations
  • 0Altmetric

Review

Review
Bioreactor concepts for cell culture-based viral vaccine production
Lilí Esmeralda Gallo–Ramírez, Alexander Nikolay, Yvonne Genzel & Udo Reichl
Pages: 1181-1195
Published online: 15 Jul 2015
AbstractforBioreactor concepts for cell culture-based viral vaccine production | Full Text | References | PDF (272 KB) | Supplemental
  • 19350 Views
  • 67 CrossRef citations
  • 0Altmetric
Open Access
Review
Gold nanoparticles and vaccine development
Jorge Alberto Salazar-González, Omar González-Ortega & Sergio Rosales-Mendoza
Pages: 1197-1211
Published online: 07 Jul 2015
AbstractforGold nanoparticles and vaccine development | Full Text | References | PDF (826.8 KB)
  • 871 Views
  • 61 CrossRef citations
  • 0Altmetric
Review
Rodents as pre-clinical models for predicting vaccine performance in humans
Peggy Riese, Stephanie Trittel, Kai Schulze & Carlos A Guzmán
Pages: 1213-1225
Published online: 12 Aug 2015
AbstractforRodents as pre-clinical models for predicting vaccine performance in humans | Full Text | References | PDF (344.2 KB)
  • 203 Views
  • 7 CrossRef citations
  • 0Altmetric
Review
Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity
Adam Kenneth Wheatley & Stephen John Kent
Pages: 1227-1239
Published online: 15 Jul 2015
AbstractforProspects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity | Full Text | References | PDF (660.6 KB)
  • 541 Views
  • 12 CrossRef citations
  • 0Altmetric
Review
Progress toward norovirus vaccines: considerations for further development and implementation in potential target populations
Negar Aliabadi, Ben A Lopman, Umesh D Parashar & Aron J Hall
Pages: 1241-1253
Published online: 29 Jul 2015
AbstractforProgress toward norovirus vaccines: considerations for further development and implementation in potential target populations | Full Text | References | PDF (319.7 KB)
  • 577 Views
  • 36 CrossRef citations
  • 0Altmetric
Review
Applications of bacillus Calmette–Guerin and recombinant bacillus Calmette–Guerin in vaccine development and tumor immunotherapy
Yuan-qiang Zheng, Youssef W Naguib, Yixuan Dong, Yan-chun Shi, Shorgan Bou & Zhengrong Cui
Pages: 1255-1275
Published online: 12 Aug 2015
AbstractforApplications of bacillus Calmette–Guerin and recombinant bacillus Calmette–Guerin in vaccine development and tumor immunotherapy | Full Text | References | PDF (505.8 KB)
  • 207 Views
  • 37 CrossRef citations
  • 0Altmetric
Review
Multivalent meningococcal serogroup B vaccines: challenges in predicting protection and measuring effectiveness
Jan T Poolman & Peter Richmond
Pages: 1277-1287
Published online: 23 Jul 2015
AbstractforMultivalent meningococcal serogroup B vaccines: challenges in predicting protection and measuring effectiveness | Full Text | References | PDF (340.1 KB)
  • 540 Views
  • 13 CrossRef citations
  • 0Altmetric

Original Research

Article
Protective efficacy of two novel DNA vaccines expressing Toxoplasma gondii rhomboid 4 and rhomboid 5 proteins against acute and chronic toxoplasmosis in mice
Nian-Zhang Zhang, Ying Xu, Meng Wang, Eskild Petersen, Jia Chen, Si-Yang Huang & Xing-Quan Zhu
Pages: 1289-1297
Published online: 25 Jun 2015
AbstractforProtective efficacy of two novel DNA vaccines expressing Toxoplasma gondii rhomboid 4 and rhomboid 5 proteins against acute and chronic toxoplasmosis in mice | Full Text | References | PDF (1.1 MB)
  • 334 Views
  • 35 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Modeling the potential public health and economic impact of different COVID-19 booster dose vaccination strategies with an adapted vaccine in the United Kingdom
Cale Harrison et al.
Article | Published online: 29 Jul 2024
Open Access
Adjuvant system AS01: from mode of action to effective vaccines
Francois Roman et al.
Review Article | Published online: 23 Jul 2024
Open Access
Adaptive immune response to bordetella pertussis during vaccination and infection: emerging perspectives and unanswered questions
A-Reum Kim et al.
Review Article | Published online: 24 Jul 2024
Open Access
Lessons from a decade of adult vaccine rollout in low- and middle-income countries: a scoping review
Amelia K. Gerste et al.
Review Article | Published online: 10 Jul 2024
Open Access
View all latest articles